CareDx (NASDAQ: CDNA) and Digiliti Money Group (OTCMKTS:DGLT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends and risk.

Volatility & Risk

CareDx has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Digiliti Money Group has a beta of -0.66, indicating that its stock price is 166% less volatile than the S&P 500.

Earnings & Valuation

This table compares CareDx and Digiliti Money Group’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CareDx $40.63 million 4.99 -$39.46 million ($1.81) -3.92
Digiliti Money Group $7.97 million 0.20 -$15.16 million N/A N/A

Digiliti Money Group has lower revenue, but higher earnings than CareDx.

Profitability

This table compares CareDx and Digiliti Money Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CareDx -84.14% -157.00% -23.52%
Digiliti Money Group -147.73% N/A -199.21%

Institutional and Insider Ownership

23.1% of CareDx shares are held by institutional investors. Comparatively, 11.3% of Digiliti Money Group shares are held by institutional investors. 5.4% of CareDx shares are held by insiders. Comparatively, 50.9% of Digiliti Money Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations for CareDx and Digiliti Money Group, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareDx 0 0 4 0 3.00
Digiliti Money Group 0 0 1 0 3.00

CareDx currently has a consensus price target of $8.88, suggesting a potential upside of 25.18%. Digiliti Money Group has a consensus price target of $6.00, suggesting a potential upside of 3,650.00%. Given Digiliti Money Group’s higher probable upside, analysts clearly believe Digiliti Money Group is more favorable than CareDx.

Summary

CareDx beats Digiliti Money Group on 7 of the 11 factors compared between the two stocks.

About CareDx

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company’s commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.

About Digiliti Money Group

Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.

Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.